These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 4795170

  • 1. [Treatment of parkinsonism with the drug L-DOPA].
    Stoliarova LG, Kistenev BA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
    [No Abstract] [Full Text] [Related]

  • 2. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E, D'Andrea F, Signorelli CD.
    Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
    [No Abstract] [Full Text] [Related]

  • 3. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F, Baroni A, Roveyaz L.
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract] [Full Text] [Related]

  • 4. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F, Grünberger J, Schubert H.
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Parkinsonism and dopa.
    N Z Med J; 1969 May; 69(444):306-7. PubMed ID: 5256210
    [No Abstract] [Full Text] [Related]

  • 11. [Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results].
    Bergamini L, Bonzanino O, Brignolio F, Fabiani A, Fariello R, Mombelli AM, Mutani R, Pisani W, Postir A, Riccio A, Sabbatini F, Sandigliano G, Schiffer D.
    Riv Patol Nerv Ment; 1969 Oct; 90(5):329-49. PubMed ID: 5406104
    [No Abstract] [Full Text] [Related]

  • 12. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW, Deze J, Gundlach U, Muschard F.
    Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994
    [No Abstract] [Full Text] [Related]

  • 13. [Study of L-dopa treatment and its principal side effects in aged subjects].
    Antonini F, Baroni A, Bucalossi A, Roveyaz L.
    Gerontol Clin (Basel); 1972 Nov; 14(5):297-309. PubMed ID: 4144357
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. L-dopa for parkinsonism.
    Reveno WS, Bauer RB, Rosenbaum H.
    Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.